Inventor · disambiguated record
Jaclyn Louise Henderson
Also filed as: HENDERSON JACLYN L · HENDERSON JACLYN LOUISE
18 granted patents·5 pending applications·85 citations·filing 2013–2024
93Inventor score
Top patents by PatentIndex Score
23 records- 0194US9107923B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Aug 18, 2015·11 cites·30 claims
- 0293US9527831B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2014·Granted Dec 27, 2016·13 cites·30 claims
- 0393US9139561B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Sep 22, 2015·8 cites·30 claims
- 0491US9822097B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2016·Granted Nov 21, 2017·6 cites·15 claims
- 0590US10039753B2Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitorsPFIZER·Filed 2016·Granted Aug 7, 2018·14 cites·29 claims
- 0689US2024317713A1Heteroaromatic compounds and their use as dopamine d1 ligandsPFIZER·Filed 2024·Application pending·0 cites
- 0787US9642855B2Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2015·Granted May 9, 2017·6 cites·10 claims
- 0887US9617275B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Apr 11, 2017·5 cites·18 claims
- 0986US10093655B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2017·Granted Oct 9, 2018·3 cites·20 claims
- 1086US9695171B23,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitorsPFIZER·Filed 2014·Granted Jul 4, 2017·10 cites·7 claims
- 1184US10421744B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2018·Granted Sep 24, 2019·2 cites·20 claims
- 1283US9156845B24-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2013·Granted Oct 13, 2015·6 cites·24 claims
- 1377US11964961B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 1474US11014909B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2020·Granted May 25, 2021·0 cites·22 claims
- 1574US10696658B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2019·Granted Jun 30, 2020·0 cites·13 claims
- 1673US11161844B2Cyclic substituted imidazo[4,5-c]quinoline derivativesPFIZER·Filed 2018·Granted Nov 2, 2021·1 cites·18 claims
- 1765US2024208923A1Small molecule inhibitors of mammalian slc6a19 functionJNANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1862US2017165270A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2017·Application pending·0 cites
- 1962US2015291625A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2013·Application pending·0 cites
- 2060US2018200253A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2018·Application pending·0 cites
- 2156US11390623B26,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligandsPFIZER·Filed 2020·Granted Jul 19, 2022·0 cites·40 claims
- 2248US11312713B2Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitorsPFIZER·Filed 2018·Granted Apr 26, 2022·0 cites·18 claims
- 2346US10590128B26,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligandsPFIZER·Filed 2017·Granted Mar 17, 2020·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →